Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting GlobeNewswire December 06, 2025 Designed with our proprietary AI-Immunology(TM) platform based on patient sequencing data, EVX-04 targets multiple non-conventional endogenous retrovirus (ERV) tumor antigens EVX-04 induces targeted immune responses and prevents tumor growth in preclinical models EVX-04 […]

Legend Biotech Highlights New CARVYKTI(R) Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025 GlobeNewswire December 06, 2025 Triple-class exposed patients with three prior lines of therapy in CARTITUDE-1 and CARTITUDE-4 achieved a median PFS of 50.4 months after a single infusion of CARVYKTI(R) Translational analyses show

New York, New York–(Newsfile Corp. – December 6, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of James Hardie Industries plc (NYSE: JHX) between May 20, 2025 through August 18, 2025, both dates inclusive (the “Class Period”) of the important December 23, 2025 lead plaintiff deadline. SO

(NASDAQ:ONCY),(Other OTC:AVAI),(NasdaqGM:VWAV),(CNSX:GOH.CN),(Other OTC:GHVNF),(TSX-V:VPT),(Other OTC:VPTDF), VANCOUVER, British Columbia, Dec. 06, 2025 (GLOBE NEWSWIRE) — USANewsGroup.com Market Intelligence Brief – The market is efficient… until it isn't. While the S&P 500 grinds higher on momentum, entire subsectors have been left behind, creating a massive disconnect between Operational Reality and Stock Price. They are quietly rotating into specific,

THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality Issued on behalf of Oncolytics Biotech Inc. GlobeNewswire December 06, 2025 VANCOUVER, British Columbia, Dec. 06, 2025 (GLOBE NEWSWIRE) — USANewsGroup.com Market Intelligence Brief – The market is efficient… until it isn't. While the S&P 500 grinds higher on momentum, entire subsectors have been left behind,

Copper Property CTL Pass Through Trust (“the Trust”) has filed a Form 8-K containing its monthly report for the period ended November 30, 2025. An aggregate total distribution of $6.8 million or $0.090060 per trust certificate will be paid on December 10, 2025, to certificate holders of record as of December 9, 2025. https://mma.prnewswire.com/media/2839931/Copper_Property___LOGO_1764970209V2XMn9icQY_1764972903rhhPBDy01l_915x258.jpg Additional

(NYSE:AGL), NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public. SO WHAT: If

AGL Investor News: If You Have Suffered Losses in agilon health, inc. (NYSE: AGL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire December 06, 2025 NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on

(NASDAQ:MLTX), SAN FRANCISCO, Dec. 06, 2025 (GLOBE NEWSWIRE) — Global plaintiffs' rights law firm Hagens Berman reminds investors that the deadline to move the Court for appointment as lead plaintiff in the securities class action lawsuit against MoonLake Immunotherapeutics, Inc. (NASDAQ: MLTX) is December 15, 2025. “In specialized biotech cases, the core legal question is

MLTX 9-DAY DEADLINE ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate — Hagens Berman Lead Partner Reed Kathrein Investigating Alleged Undisclosed Truth: Did SLK's Nanobody Structure Truly Confer a Superior Clinical Benefit Over Monoclonal Antibodies? GlobeNewswire December 06, 2025 SAN FRANCISCO, Dec. 06,